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Detection of Left Atrial Appendage Thrombus by
Cardiac Computed Tomography
A Word of Caution*
Mario J. Garcia, MD, FACC
New York, New YorkIn this issue of iJACC, Martinez et al. (1) report
their experience with cardiac computed tomography
(CCT) to detect left atrial appendage thrombi in
patients with atrial fibrillation undergoing pulmo-
nary vein radiofrequency ablation.
Atrial fibrillation is one of the most common
cardiovascular disorders, carrying significant mor-
bidity, including cardio-embolic stroke and heart
failure. Slow flow in the left atrial appendage, also
called spontaneous echo contrast, as well as left
atrial thrombi have been associated with an in-
creased risk of embolic stroke in patients evaluated
by transesophageal echocardiography (TEE) (2).
Evaluation by TEE is a safe, clinically accepted
strategy for the assessment of atrial thrombus before
cardioversion in patients with atrial fibrillation who
have not received prolonged anticoagulation (3).
See page 69
Percutaneous pulmonary vein radiofrequency ab-
lation has become a popular alternative to antiar-
rhythmic therapy for the management of atrial
fibrillation. Because the presence of thrombi in the
left atrial appendage is considered to increase the
risk of cardioembolic stroke in patients undergoing
this procedure, some investigators have recom-
mended routine evaluation by TEE. Patients re-
ferred for ablation procedures also frequently un-
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
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vascular Institute, Mount Sinai Hospital, New York, New York. The
author has received honoraria as a consultant and/or speaker from Philips
Medical Systems, Astra-Zeneca, Abbott, and BG Medicine.dergo contrast-enhanced CCT for 3-dimensional
definition of the atrial and pulmonary vein anatomy
and identification of the esophageal location. In
most experienced centers, CCT images are inte-
grated with electrophysiological mapping to guide
the procedure. Because current high-resolution
CCT studies can define the anatomy of the left
atrial appendage, the utility of this procedure to
exclude thrombi has been recently investigated with
the hope of eliminating the need to perform routine
evaluation by TEE, a procedure that carries signif-
icant discomfort.
In this study, Martinez et al. (1) evaluated 402
consecutive patients undergoing radiofrequency ab-
lation for atrial fibrillation at the Mayo Clinic. All
patients had both contrast-enhanced CCT and
TEE studies performed within 3 days of each other.
There were 362 patients without evidence of
thrombi by either method. The CCT identified 40
patients with a filling defect in the appendage, 9 of
which were confirmed by TEE as thrombi, whereas
the rest were shown to have spontaneous echo
contrast. Accordingly, their reported sensitivity and
specificity for the detection of thrombi by CCT,
with TEE as the reference standard, were 100% and
92%, respectively.
This study represents one of the largest series
published to this date, and contrary to most previous
publications, it used a nonelectrocardiography
(ECG)-gated acquisition protocol. Although not suit-
able for coronary imaging, nongated CCT provides
sufficient spatial resolution for visualization of the left
atrium and pulmonary veins but a significantly lower
radiation exposure compared with ECG-gated acqui-
sition. Following the principles of ALARA (as low as
reasonably achievable), the results of this study should
have discouraged the routine use of ECG-gated ac-
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78uisition in this setting, because the information
rovided is equivalent but with a lower potential
ealth risk. However, in a recent series of 170 patients
ublished by Tang et al. (4), with a similar non–
CG-gated CCT, only 4 of 11 thrombi found by
EE were detected by CCT. It is conceivable that
otion artifacts of the left atrial appendage in non–
CG-gated studies might prevent the identification
f small thrombi.
Although the study by Martinez et al. (1)
eports high specificity (362 of 393, 92%), posi-
ive predictive value is very low (9 of 40, 23%).
hus, most patients with a positive CCT finding
o not have thrombi and should not have their
blation procedure canceled. In these, a confir-
atory TEE is required. Poor contrast opacifica-
ion of the appendage is often caused by slow
ow, because image acquisition is performed
ithin seconds of contrast injection. In our prac-
ice, we perform routine delayed partial scanning
f the appendage 1 to 2 min after the initial scan
Fig. 1). In most false positive cases, contrast
pacification of the appendage tip will be dem-
nstrated in the delayed scan.
How should the study of Martinez et al. (1)
lter our practice? Clearly, the prevalence of
hrombi in the Martinez et al. (1) study as well as
n previous studies and in our own experience (5)
n this setting has been very low. Most patients
ncluded are younger, many have paroxysmal
trial fibrillation without structural heart disease,
nd most have been anticoagulated before the
rocedure. Therefore, we cannot conclude with
ertainty that multidetector computed tomogra-
Figure 1. Axial Image of a Cardiac Computed Tomography Study Pe
(A) Initial image obtained after contrast injection demonstrates ﬁllin
1 min after initial scan shows homogeneous opaciﬁcation, suggestihy would be sensitive enough to exclude Ehrombi in a higher-risk, higher-prevalence pop-
lation. Accordingly, we have to interpret these
esults with caution. Moreover, in the absence of
linical outcome data, CCT should not be used as
n alternative to TEE in other settings, such as
efore electrical cardioversion.
On the basis of the results of this and previously
ublished studies, we feel that younger patients and
hose with a low congestive heart failure, hyperten-
ion, age older than 75 years, and diabetes score
ould safely undergo radiofrequency ablation with-
ut TEE after a negative non–ECG-gated CCT.
he use of nongated CCT is particularly desirable
n younger patients, because radiation dose is sub-
tantially lower than in ECG-gated CT imaging.
owever, we feel that this study does not provide
ufficient data to support the use of CCT to rule out
trial thrombi in patients who are older and/or have
higher congestive heart failure, hypertension, age
lder than 75 years, and diabetes score. Because of
he low positive predictive value found in the
artinez study, incomplete visualization of the
ppendage or uneven opacification should prompt
EE or intracardiac echocardiographic evaluation
f the appendage before left atrial instrumentation,
o verify the presence or absence of thrombi. In the
eantime, the value of delayed and cine-CT imag-
ng should be evaluated in clinical series, and larger
tudies should be conducted to assess the diagnostic
ield of CCT in higher-risk populations.
eprint requests and correspondence: Dr. Mario J Garcia,
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ustave Levy Place, New York, New York 10029.
ed in a Patient Before Radiofrequency Pulmonary Vein Ablation
efect in the left atrial appendage tip. (B) Delayed image obtained
n absence of thrombus. F  feet.rform
g d-mail: Mario.garcia@mountsinai.org.
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